Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Bodey

Showing results (421-430 of 726) with videos related to

Pageof 73
Sort By:
Journal of Clinical Microbiology|July 1, 1982
Diagnostic value of the enzyme-linked immunosorbent assay for detection of Candida albicans cytoplasmic antigen in sera of cancer patientsG F Araj, R L Hopfer, S Chesnut, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1987
In-vitro activity of LY146032 against gram-positive isolates from cancer patientsH Saito, K V Rolston, D H Ho, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1980
Intensive induction chemotherapy of extensive small cell bronchogenic carcinoma in protected environment--prophylactic antibiotic units. A preliminary reportM Valdivieso, F Cabanillas, H T Barkley, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1990
The activity in vitro of trospectomycin sulphate (U-63366F) against aminoglycoside-resistant enterococciN Khardori, M Gandhi, J Adame, et al.
Chest|October 1, 1988
Bronchoalveolar lavage in the diagnosis of pulmonary infiltrates in patients with acute leukemiaH Saito, E J Anaissie, R C Morice, et al.
American Journal of Clinical Oncology|August 1, 1983
Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with upper gastrointestinal tumors. A preliminary reportA Y Bedikian, J Stroehlein, J Korinek, et al.
American Journal of Clinical Oncology|June 1, 1982
Phase II trail of PCNU in refractory advanced breast cancerJ J Kavanagh, H Y Yap, G R Blumenschein, et al.
Southern Medical Journal|August 1, 1981
Colorectal cancer in young adultsA Y Bedikian, H Kantarjian, R S Nelson, et al.
Cancer Treatment Reports|September 1, 1984
Phase II study of spirogermanium in the treatment of metastatic breast cancerK Pinnamaneni, H Y Yap, S S Legha, et al.
American Journal of Clinical Oncology|February 1, 1983
Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with metastatic colorectal cancerA Y Bedikian, J Stroehlein, J Korinek, et al.
Pageof 73

Showing results (421-430 of 726) with videos related to

Sort By:
Pageof 73
Journal of Clinical Microbiology|July 1, 1982
Diagnostic value of the enzyme-linked immunosorbent assay for detection of Candida albicans cytoplasmic antigen in sera of cancer patientsG F Araj, R L Hopfer, S Chesnut, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1987
In-vitro activity of LY146032 against gram-positive isolates from cancer patientsH Saito, K V Rolston, D H Ho, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1980
Intensive induction chemotherapy of extensive small cell bronchogenic carcinoma in protected environment--prophylactic antibiotic units. A preliminary reportM Valdivieso, F Cabanillas, H T Barkley, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1990
The activity in vitro of trospectomycin sulphate (U-63366F) against aminoglycoside-resistant enterococciN Khardori, M Gandhi, J Adame, et al.
Chest|October 1, 1988
Bronchoalveolar lavage in the diagnosis of pulmonary infiltrates in patients with acute leukemiaH Saito, E J Anaissie, R C Morice, et al.
American Journal of Clinical Oncology|August 1, 1983
Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with upper gastrointestinal tumors. A preliminary reportA Y Bedikian, J Stroehlein, J Korinek, et al.
American Journal of Clinical Oncology|June 1, 1982
Phase II trail of PCNU in refractory advanced breast cancerJ J Kavanagh, H Y Yap, G R Blumenschein, et al.
Southern Medical Journal|August 1, 1981
Colorectal cancer in young adultsA Y Bedikian, H Kantarjian, R S Nelson, et al.
Cancer Treatment Reports|September 1, 1984
Phase II study of spirogermanium in the treatment of metastatic breast cancerK Pinnamaneni, H Y Yap, S S Legha, et al.
American Journal of Clinical Oncology|February 1, 1983
Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with metastatic colorectal cancerA Y Bedikian, J Stroehlein, J Korinek, et al.
Pageof 73